Submit Comments on Tobacco Products
You have saved this web page content. To access this content for publishing, go to My Web Content.
Preview Text for Your Web Page
The following text is a preview of content you can place on your website. After you save it to Your Web Content, we will provide you with a line of code to publish on your website. The text will appear in the style of your website.
Make your voice heard and be part of our ongoing effort to improve public health in the United States.
We solicit information and comments, announced in the Federal Register and posted in dockets on Regulations.gov, from concerned citizens, industry, and organizations on a wide range of issues related to implementation of the Tobacco Control Act.
Request for Information on Vaping Products Associated With Lung Injuries
Docket No: FDA-2020-N-0597
Comment Period End Date: April 20, 2020
Summary: The Food and Drug Administration (FDA) is opening a docket to obtain data and information related to the use of vaping products that are associated with recent lung injuries. This request for information (RFI) responds to direction from Congress to gather information from the public that could help identify and evaluate additional steps the Agency could take to “address the recent pulmonary illnesses reported to be associated with the use of e-cigarettes and vaping products.” FDA is seeking information on product design and potential ways to prevent consumers from modifying or adding substances to these products that are not intended by the manufacturers. In particular, FDA is seeking data and information in the form of reports and manuscripts that are unpublished or not available through indexed bibliographic databases. FDA has searched the publicly available scientific literature and is now seeking to supplement that with information not included in the published scientific literature.
Modified Risk Tobacco Product Applications: Applications for IQOS System With Marlboro Heatsticks, IQOS System With Marlboro Smooth Menthol Heatsticks, and IQOS System With Marlboro Fresh Menthol Heatsticks Submitted by Philip Morris Products S.A. (re-opening of comment period)
Docket No: FDA-2017-D-3001
Comment Period End Date: February 24, 2020
Summary: On January 24, 2020, the Food and Drug Administration (FDA) opened a 30-day period for public comment on an amendment submitted by Philip Morris Products S.A to the company’s modified risk tobacco product applications (MRTPAs) for its IQOS system with Marlboro Heatsticks, IQOS system with Marlboro Smooth Menthol Heatsticks, and IQOS system with Marlboro Fresh Menthol Heatsticks.
The Tobacco Products Scientific Advisory Committee; Notice of Meeting
Docket No: FDA-2019-N-0001
Deadlines: Requests to present an oral comment at the meeting must be received by January 30, 2020. Written comments related to the TPSAC meeting must be received by February 7, 2020.
Summary: The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Tobacco Products Scientific Advisory Committee (TPSAC, the Committee). The general function of the Committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. The meeting will be open to the public.
Modified Risk Tobacco Product Applications for VLN™ King, VLN™ Menthol King, Combusted, Filtered Cigarettes, Submitted by 22nd Century Group Inc.
Docket No: FDA-2019-N-0994
Comment Period End Date: Currently no deadline for public comments
Summary: The FDA is announcing the availability for public comment of modified risk tobacco product applications for VLNTM King and VLNTM Menthol King, combusted, filtered cigarettes, submitted by 22nd Century Group Inc. FDA will post the application materials on a rolling basis as they are redacted in accordance with applicable laws.
Modified Risk Tobacco Product Applications: Application for Copenhagen Snuff Fine Cut submitted by U.S. Smokeless Tobacco Company; Availability
Docket No: FDA‐2018‐N-3261
Comment Period End Date: January 21, 2020
Summary: The FDA is announcing the availability for public comment of a modified risk tobacco product (MRTP) application for Copenhagen Snuff Fine Cut, a loose moist snuff tobacco product submitted by U.S. Smokeless Tobacco Company LLC. FDA will post the application materials on a rolling basis as they are redacted in accordance with applicable laws.
What makes an effective and useful comment?
Our decisions are based on science and law. We look for logic, good science, and other evidence in the comments we evaluate.
- Provide a clear statement of whether you support or oppose the proposed rule or guidance.
- Include any of the following that support your position:
- Read more tips for submitting effective comments on the regulations.gov website.
Your role in shaping tobacco regulation
Our regulatory process generally follows these steps:
We publish a proposed rule in the Federal Register.
Public Comments Considered
Our proposals generally have a 60-90 day review period.
Final Rule Issued
After considering all comments, we issue a final rule.
Compliance with New Rule Enforced
We must ensure that retailers and businesses comply with the regulation.